Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients

This study has been completed.
Sponsor:
Information provided by:
Deutsches Herzzentrum Muenchen
ClinicalTrials.gov Identifier:
NCT00196287
First received: September 13, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
  Purpose

The purpose of this study was to investigate differences in risk prediction in female post-infarction patients.


Condition
Myocardial Infarction

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Official Title: Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients

Resource links provided by NLM:


Further study details as provided by Deutsches Herzzentrum Muenchen:

Estimated Enrollment: 750
Study Start Date: January 1995
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

acute myocardial infarction; female gender

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00196287

Locations
Germany
Deutsches Herzzentrum Muenchen
Munich, Germany, 80636
1. Medizinische Klinik, Klinikum rechts der Isar
Munich, Germany, 81675
Sponsors and Collaborators
Deutsches Herzzentrum Muenchen
Investigators
Study Chair: Georg Schmidt, MD Deutsches Herzzentrum Muenchen
Study Director: Petra Barthel, MD Deutsches Herzzentrum Muenchen
Principal Investigator: Axel Bauer, MD Deutsches Herzzentrum Muenchen
  More Information

Additional Information:
Publications:
ClinicalTrials.gov Identifier: NCT00196287     History of Changes
Other Study ID Numbers: GE IDE No. R00395
Study First Received: September 13, 2005
Last Updated: September 13, 2005
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

Keywords provided by Deutsches Herzzentrum Muenchen:
Assessment, risk
autonomic nervous system
Gender

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on April 17, 2014